FMR LLC
SEC CIK 315066 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BEAM | Beam Therapeutics Inc. | See Remark 1 | 854.6K | — | $40.83M | 15 | 2021-08-06 | 2026-06-25 |
| AVLN | Avalyn Pharma Inc. | 10%, See Remark 1 | 2.28M | — | — | 1 | 2026-05-01 | 2026-05-01 |
| SANA | Sana Biotechnology, Inc. | 10%, See Remark 1 | 4.71M | — | $1.89M | 1 | 2025-01-08 | 2025-01-08 |
| BCAX | Bicara Therapeutics Inc. | See Remark 1 | 1.12M | — | — | 1 | 2024-09-16 | 2024-09-16 |
| NMRA | Neumora Therapeutics, Inc. | See Remark 1 | 88.3K | — | — | 1 | 2023-09-19 | 2023-09-19 |
| GPCR | Structure Therapeutics Inc. | See Remark 1 | 57.5K | — | — | 1 | 2023-02-07 | 2023-02-07 |
| PRME | Prime Medicine, Inc. | See Remark 1 | 99.0K | — | — | 1 | 2022-10-24 | 2022-10-24 |
| XLO | Xilio Therapeutics, Inc. | See Remark 1 | 815.8K | — | — | 1 | 2021-10-26 | 2021-10-26 |
| RLYB | Rallybio Corp | See Remark 1 | 1.69M | — | — | 1 | 2021-08-02 | 2021-08-02 |
| CRBU | Caribou Biosciences, Inc. | See Remark 1 | 770.5K | — | — | 1 | 2021-07-27 | 2021-07-27 |
Most active insiders at BEAM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FMR LLC | 10%, See Remark 1 | — | $10.05M |
| 2 | Evans John M. | CEO, Dir | — | $6.28M |
| 3 | Ciaramella Giuseppe | Pres | — | $1.41M |
| 4 | Bellon Christine | CLO | — | $881.0K |
| 5 | Simon Amy | Chief Medical Off | — | $606.7K |
| 6 | Cavanagh Bethany J | SVP, Fin, Treas | — | $399.5K |
| 7 | Emany Sravan Kumar | CFO | — | $170.6K |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-06-29 14:17 | 2026-06-25+ | BEAM | Beam Therapeutics Inc. | FMR LLC | 10%, See Remark 1 | S - Sale | $35.24 | -284.9K | 854.6K | -25% | -$10.04M |
| DMI | 2026-05-05 08:37 | 2026-05-01 | AVLN | Avalyn Pharma Inc. | FMR LLC | 10%, See Remark 1 | C - Cnv Deriv | — | +2.28M | 2.28M | New | — |
| I | 2025-10-29 | 2025-10-27 | BEAM | Beam Therapeutics Inc. | FMR LLC | 10%, See Remark 1 | S - Sale | $26.68 | -459 | 14 | -97% | -$12.2K |
| I | 2025-10-08 | 2025-10-06 | BEAM | Beam Therapeutics Inc. | FMR LLC | 10%, See Remark 1 | G - Gift | $0.00 | -1.23M | 841.2K | -59% | $0 |
| I | 2025-08-01 | 2025-07-30 | BEAM | Beam Therapeutics Inc. | FMR LLC | 10%, See Remark 1 | S - Sale | $20.50 | -48.4K | 2.07M | -2% | -$991.7K |
| MI | 2025-01-10 | 2025-01-08 | SANA | Sana Biotechnology, Inc. | FMR LLC | 10%, See Remark 1 | S - Sale | $6.49 | -290.9K | 4.71M | -6% | -$1.89M |
| DMI | 2024-09-18 | 2024-09-16 | BCAX | Bicara Therapeutics Inc. | FMR LLC | See Remark 1 | C - Cnv Deriv | — | +1.12M | 1.12M | New | — |
| MI | 2024-02-15 | 2024-02-13+ | BEAM | Beam Therapeutics Inc. | FMR LLC | See Remark 1 | S - Sale | $30.55 | -901.6K | 2.77M | -25% | -$27.55M |
| I | 2023-12-27 | 2023-12-22 | BEAM | Beam Therapeutics Inc. | FMR LLC | 10%, See Remark 1 | J - Other | $0.00 | -29.5K | 2.77M | -1% | $0 |
| DMI | 2023-09-21 | 2023-09-19 | NMRA | Neumora Therapeutics, Inc. | FMR LLC | See Remark 1 | C - Cnv Deriv | — | +3.71M | 88.3K | New | — |
| DMI | 2023-02-09 | 2023-02-07 | GPCR | Structure Therapeutics Inc. | FMR LLC | See Remark 1 | C - Cnv Deriv | — | +5.82M | 57.5K | New | — |
| DMI | 2022-10-26 | 2022-10-24 | PRME | Prime Medicine, Inc. | FMR LLC | See Remark 1 | C - Cnv Deriv | — | +8.46M | 99.0K | New | — |
| MI | 2022-09-08 | 2022-09-06 | BEAM | Beam Therapeutics Inc. | FMR LLC | 10%, See Remark 1 | J - Other | $0.00 | -25.1K | 0 | -100% | $0 |
| I | 2022-09-08 | 2022-09-06 | BEAM | Beam Therapeutics Inc. | FMR LLC | 10%, See Remark 1 | S - Sale | $54.25 | -551 | 0 | -100% | -$29.9K |
| MI | 2022-08-08 | 2022-08-04 | BEAM | Beam Therapeutics Inc. | FMR LLC | 10%, See Remark 1 | J - Other | $0.00 | -454.4K | 193.2K | -70% | $0 |
| MI | 2022-08-08 | 2022-08-05 | BEAM | Beam Therapeutics Inc. | FMR LLC | 10%, See Remark 1 | S - Sale | $60.50 | -20.3K | 0 | -100% | -$1.23M |
| MI | 2022-04-14 | 2022-04-12 | BEAM | Beam Therapeutics Inc. | FMR LLC | 10%, See Remark 1 | J - Other | $0.00 | -531.3K | 18.8K | -97% | $0 |
| MI | 2022-04-14 | 2022-04-13 | BEAM | Beam Therapeutics Inc. | FMR LLC | 10%, See Remark 1 | S - Sale | $50.41 | -19.5K | 3,200 | -86% | -$981.2K |
| DMI | 2021-10-28 | 2021-10-26 | XLO | Xilio Therapeutics, Inc. | FMR LLC | See Remark 1 | C - Cnv Deriv | — | +1.88M | 815.8K | New | — |
| MI | 2021-08-26 | 2021-08-24+ | BEAM | Beam Therapeutics Inc. | FMR LLC | See Remark 1 | J - Other | $0.00 | -819.9K | 304 | -100% | $0 |
| MAI | 2021-08-16 | 2021-08-06+ | BEAM | Beam Therapeutics Inc. | FMR LLC | 10%, See Remark 1 | J - Other | $0.00 | -507.4K | 724 | -100% | $0 |
| MI | 2021-08-10 | 2021-08-06+ | BEAM | Beam Therapeutics Inc. | FMR LLC | See Remark 1 | J - Other | $0.00 | -1.46M | 0 | -100% | $0 |
| DI | 2021-08-04 | 2021-08-02 | RLYB | Rallybio Corp | FMR LLC | See Remark 1 | C - Cnv Deriv | — | +1.69M | 1.69M | New | — |
| DMI | 2021-07-29 | 2021-07-27 | CRBU | Caribou Biosciences, Inc. | FMR LLC | See Remark 1 | C - Cnv Deriv | — | +3.32M | 770.5K | New | — |
Purchase Sale Sale after option exercise All abbreviations